Ovid Therapeutics Inc stock is traded at $2.85, with a volume of 6,224,780. It is up 0.00% in the last 24 hours and up +15.85% over the past month. Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
Previous Close:
$2.85
Open:
$2.89
24h Volume:
6,224,780
Relative Volume:
2.19
Market Cap:
$556.60M
Revenue:
$7.12M
Net Income/Loss:
-$24.17M
P/E Ratio:
-
EPS:
-$0.2434
Net Cash Flow:
-$41.95M
1W Performance:
+18.75%
1M Performance:
+15.85%
6M Performance:
+1.79%
1Y Performance:
+111.11%
1-Day Range:
$2.83$3.09
1-Week Range:
$2.38$3.09
52-Week Range:
$1.18$3.11
Ovid Therapeutics Inc Stock (OVID) Company Profile
Name
Ovid Therapeutics IncSector
HealthcareIndustry
BiotechnologyPhone
212-776-4381Address
441 NINTH AVENUE, 14TH FLOOR, NEW YORK, NY, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS